DERMA SCIENCES, INC. 4
4 · DERMA SCIENCES, INC. · Filed Apr 7, 2016
Insider Transaction Report
Form 4
Hewlett Brett
Director
Transactions
- Exercise of In-Money
Series Q Warrants
2015-01-29−133,333→ 0 total(indirect: By Comvita Limited)Exercise: $5.50From: 2010-02-23Exp: 2015-02-22→ Common Stock (133,333 underlying) - Exercise of In-Money
Common Stock
2015-01-29$5.50/sh+133,333$733,332→ 1,131,963 total(indirect: By Comvita Limited) - Exercise of In-Money
Series N Warrants
2015-01-29−100,000→ 0 total(indirect: By Comvita Limited)Exercise: $6.25From: 2010-02-23Exp: 2015-02-22→ Common Stock (100,000 underlying) - Exercise of In-Money
Common Stock
2015-01-29$6.25/sh+100,000$625,000→ 998,630 total(indirect: By Comvita Limited)
Footnotes (4)
- [F1]The acquisition of the securities reported herein resulted from the exercise by Comvita Limited of derivative securities (Series N and Series Q Warrants) exempt under Exchange Act Rule 16b-6(b).
- [F2]The securities reported herein are held by Comvita Limited. Brett Hewlett is the former Chief Executive Officer and a current Advisor to the Board of Directors of Comvita Limited and therefore may be deemed to share voting and investment power with respect to these securities held by Comvita Limited. Mr. Hewlett disclaims beneficial ownership of these securities held by Comvita Limited.
- [F3]The disposition of the securities reported herein resulted from the exercise by Comvita Limited of in-the-money derivative securities (Series N and Series Q Warrants) exempt under Rule 16b-6(b).
- [F4]The securities reported herein were originally issued to Comvita Limited on February 23, 2010.